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SIFAT PERTUMBUHAN DAN BIOAKTIVITI LAKTOBACILLI 
DALAM SUSU SOYA YANG DITAMBAH VITAMIN B DAN SELEPAS 
PENGOLAHAN FIZIKAL  
 
ABSTRAK 
Ciri-ciri pertumbuhan, potensi bioaktif dan bio-penukaran isoflavon dalam 
susu soya diperkaya dengan vitamin B bagi Lactobacillus acidophilus BT 1088, L. 
fermentum BT 8219, L. acidophilus FTDC 8633 dan L. gasseri FTDC 8131 
dinilaikan. Kesannya ke atas sifat pertumbuhan didapati bergantung pada strain 
bakteria serta jenis vitamin B yang ditambahkan. Pertumbuhan sel meningkat kepada 
hitungan viabel melebihi 7 log10 CFU/mL. Aktiviti spesifik -galaktosidase 
meningkat dengan penambahan vitamin B lalu meningkatkan hidrolisis oligosakarida 
soya, diiringi peningkatan penghasilan laktat dan asetat setelah fermentasi. Aktiviti 
proteolitis Lactobacillus meningkat, menyumbang kepada penghasilan susu soya 
diperkaya vitamin B terfermen dengan aktiviti perencatan ACE yang lebih tinggi. 
Aktiviti spesifik -glukosidase juga meningkat, menyebabkan peningkatan 
kepekatan aglikon dalam susu soya yang diperkaya. 
 Penambahan biotin yang telah meningkatkan kandungan aglikon yang tinggi 
dalam susu soya selepas fermentasi dipilih sebagai suplemen untuk kajian 
selanjutnya yang melibatkan rawatan fizikal yang bertujuan meningkatkan 
pertumbuhan serta aktiviti bio-penukaran isoflavon. Pengolahan fizikal, yakni 
ultrasonikasi, elektroporasi dan radiasi ultra lembayung, ke atas sel-sel bakteria 
meningkatkan ketelapan membran sel secara signifikan dengan peningkatan 
keamatan dan jangka masa pengolahan. Pengolahan fizikal telah mengaruh 
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kerosakan oksidatif yang berkait dengan peroksidaan lipid dan perubahan 
kebendaliran membran. Peningkatan ketelapan membran telah menggalakkan 
pertumbuhan sel-sel yang terolah sehingga menjangkau 8 log10 CFU/mL, dikaitkan 
dengan peningkatan aktiviti spesifik -glukosidase, menyumbang kepada aktiviti 
bio-penukaran isoflavon serta pengumpulan aglikon isoflavon yang lebih tinggi. 
 Potensi kesan pengolahan fizikal ini menjejaskan pertumbuhan, bio-
penukaran isoflavon dan sifat probiotik tiga sub-kultur sel-sel yang berikutan dikaji. 
Susu soya diperkaya dengan biotin yang terfermentasi oleh L. acidophilus FTDC 
8633 yang terolah ultrasonikasi pada 60W selama 2 minit, L. fermentum BT 8219 
yang terolah elektroporasi pada 7.5 kV/cm selama 3.5 ms, L. fermentum BT 8219 
yang terolah radiasi ultra lembayung pada 60 J/m
2
 masing-masing menunjukkan 
pengumpulan aglikon isoflavon yang paling tinggi telah dipilih. Pertumbuhan, 
aktiviti -glukosidase intrasel dan ekstrasel serta bio-penukaran isoflavon bagi 
Lactobacillus tidak diwarisi oleh sel-sel yang diolah secara fizikal bagi sub-kultur 
pertama, kedua dan ketiga. Pengolahan fizikal telah menurunkan keupayaan toleransi 
terhadap asid (pH 2) dan garam hempedu; menurunkan aktiviti perencatan terhadap 
patogen-patogen tertentu; serta merendahkan kebolehan lekatan, dibandingkan 
dengan set kawalan; akan tetapi sifat probiotik ini meningkat dalam sel-sel sub-kultur 
berikutnya.  
Kajian ini menunjukkan bahawa penambahan vitamin B dan pengolahan 
fizikal ke atas Lactobacillus dapat meningkatkan penghasilan isoflavon aglikon 
dalam susu soya selepas fermentasi untuk tujuan pengeluaran makanan berfungsi 
khusus.  
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GROWTH PROPERTIES AND BIOACTIVITIES OF LACTOBACILLI IN 
SOYMILK SUPPLEMENTED WITH B-VITAMINS AND UPON PHYSICAL 
TREATMENTS 
 
ABSTRACT 
The growth characteristics, bioactive potential and bioconversion of 
isoflavones in soymilk supplemented with B-vitamins of Lactobacillus acidophilus 
BT 1088, L. fermentum BT 8219, L. acidophilus FTDC 8633 and L. gasseri FTDC 
8131 were evaluated. The effects on the growth properties were strain- and B-
vitamin- dependent. The growth was increased to a viable count exceeding 7 log10 
CFU/mL. Supplementation of B-vitamins increased the α-galactosidase specific 
activities, thus enhanced the hydrolysis of soy oligosaccharides and substantially 
higher production of lactic and acetic acids after fermentation. Higher proteolytic 
activities also led to production of lactobacilli-fermented B-vitamin-supplemented 
soymilk with higher ACE-inhibitory activities. The β-glucosidase specific activities 
that enhanced the accumulation of isoflavone aglycones upon supplementation were 
also increased.  
Biotin supplementation that resulted in enhanced productions of aglycones in 
soymilk upon fermentation was selected for subsequent study involving physical 
treatments, aimed to further enhance the growth of lactobacilli and their isoflavones 
bioconversion activities. The physical treatments namely ultrasonication, 
electroporation and UV radiation were used to treat cells at various intensities and 
durations. The treatments induced oxidative damage on cellular membrane 
associated with the occurrence of lipid peroxidation and alteration of membrane 
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fluidity, in tandem with increasing treatment intensities and durations. The increased 
permeability promoted growth of treated cells to beyond 8 log10 CFU/mL after 
fermentation, associated with enhanced β-glucosidase specific activities. This led to 
enhanced bioconversion of isoflavones and higher accumulation of isoflavones 
aglycones.  
Potential ramifications of the treatments in affecting the growth, 
bioconversion of isoflavones and probiotic properties in subsequent three subcultures 
of cells were evaluated using biotin-soymilk fermented by ultrasonicated L. 
acidophilus FTDC 8633 at 60 W for 2 min, electroporated L. fermentum BT 8219 at 
7.5 kV/cm for 3.5 ms and UVB treated L. fermentum BT 8219 for 60 J/m
2 
as these 
showed utmost accumulation of isoflavone aglycones after fermentation. The 
growths, intracellular and extracellular β-glucosidase activities and hence aglycones 
production of the physically treated cells were not passed on by treated cells to the 
first, second and third subcultures where comparable effects were detected. Physical 
treatments reducing tolerability towards acid (pH 2) and bile; lowering inhibitory 
activities against selected pathogens and reducing adhesion ability compared to the 
control; but these probiotic properties were improved in the subsequent subcultures 
of the treated cells.  
This study shows that supplementation of B-vitamins and physical treatments 
on lactobacilli could enhance the production of isoflavone aglycones in soymilk after 
fermentation for the development of functional food.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background 
Lactobacillus belongs to one of the genera with promising probiotic 
properties that commonly inhabit the healthy gut. Probiotics have been defined by 
the FAO/WHO as ―live microorganisms which when administered in adequate 
amounts confer a health benefit to the host‖ (FAO/WHO, 2001). Conventionally, 
probiotics have been associated with improvement of intestinal health such as 
prevention and reduction of diarrhoea, improvement of intestinal microbial balance, 
protection against intestinal pathogens and alleviation of lactose intolerance 
symptoms. Over the years, the potential applications of probiotics have been 
expanded beyond gastrointestinal health to include benefits involving reduction of 
serum cholesterol, immune system stimulation, anti-hypertensive properties, anti-
mutagenic properties and anti-carcinogenic effects (Liong, 2007). Considering the 
beneficial effects of probiotics, members of the genera Lactobacillus are the most 
commercially used lactic acid bacteria for the production of functional food marketed 
worldwide.  
Soy has been claimed to exhibit health benefits to consumers and numerous 
soy-based foods have been evaluated as possible probiotic vehicles in various studies 
(Ng et al., 2008; Liong et al., 2009). Soymilk, the water extract of soybean is a rich 
source of high quality protein and amino acid. It is also free of lactose which 
warranted its acceptability by lactose-intolerant consumers, vegetarians and milk-
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allergy individuals (Wang et al., 2002). In addition to these superior nutritional 
characteristics, soymilk is also considered to have a potential role in the prevention 
of chronic diseases such as atherosclerosis, cancer, osteoporosis and menopausal 
disorders (Liu et al., 2002).  It has been claimed that soymilk can support the growth 
and biochemical activities of various lactic acid bacteria (Garro et al., 1998) and 
bifidobacteria (Chou & Hou, 2000).  
B-vitamins are a group of trace organic substances, which are essential for 
microorganism growth and metabolism. They are needed as enzyme cofactors 
involved in reactions essential for cellular functions and must be provided in the 
growth medium if a bacterium is unable to synthesize any of them. Studies have 
demonstrated that appropriate levels of B-vitamins supplementation have improved 
the lactic acid production (Xu et al., 2008) and bacteria growth (Nancib et al., 2005; 
Xu et al., 2008). Apart from microbial growth enhancement, such a supplementation 
into soymilk could also fulfil the Recommended Daily Intake (RDI) of B-vitamins by 
a human (FAO/WHO, 2004). A healthy adult is recommended to take 1.5 mg/day of 
thiamine (vitamin B1), 1.7 mg/day of riboflavin (vitamin B2), 20 mg/day of niacin 
(vitamin B3), 10 mg/day of pantothenic acid (vitamin B5), 2 mg/day of pyridoxine 
(vitamin B6), 300 μg/day of biotin (vitamin B7), 400 μg/day of folic acid (vitamin 
B9) and 6 μg/day of cobalamin (vitamin B12). However, processing of soymilk, such 
as heat treatment, may result in losses of nutritional compounds especially vitamins 
(Lešková et al., 2006). One serving (250 mL) of soymilk provides only 10% DV 
(daily value) of thiamine and riboflavin, 6% DV of niacin, 9% DV of pyridoxine and 
pantothenic acid, 11% DV of folate, and 0% DV of biotin and cobalamin (USDA, 
2009), values that are lower than the RDI. Thus, fortification of B-vitamins in 
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soymilk could aid in achieving the RDI, and is crucial for those with nutrients 
malabsorption where a higher than average nutritional supplementations is needed.          
The consumption of soymilk has been restricted due to the absence of α-
galactosidase in the human gut to breakdown the non-digestible α-galactosyl 
oligosaccharides such as raffinose and stachyose (Tsangalis & Shah, 2004). These 
intact oligosaccharides pass undigested into the lower intestine where they are 
metabolized by intestinal microflora, which produces carbon dioxide, hydrogen and 
methane, leading to flatulence and abdominal pain (Donkor et al., 2007). Studies 
have proven that fermentation of soymilk with lactic acid cultures possessing α-
galactosidase activity such as L. acidophilus results in reduced level of raffinose and 
stachyose (Hsieh & Chou, 2006; Donkor et al., 2007).  
Fermented soy products have been claimed as an excellent source of 
bioactive peptides (Yang et al., 2004). The enrichment of fermented medium with 
bioactive peptides is attributed to the proteolytic activity of microorganisms. L. 
acidophilus has been reported to exhibit proteolytic activity leading to release amino 
acids and shorter peptide chains from soy protein to meet their requirement for 
growth (Liong et al., 2009). Strains of lactobacilli have been found to produce 
proteinases that could hydrolyse long oligopeptides, liberating angiotensin-I-
converting-enzyme (ACE) inhibitory peptides (Gobbetti et al., 2000) with 
antihypertensive properties (Nakamura et al., 1995). Hence, fermentation of soymilk 
by lactobacilli could enhance the liberation of bioactive peptides especially with 
ACE inhibition activity.   
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The health benefits of soy-based food are attributable to the various 
functional ingredients in soy, especially isoflavones. Isoflavones are flavonoids 
occurring abundantly in soybean (Setchell & Cole, 2003) which comprises 80% to 
90% of biologically inactive isoflavone glucosides (Wei et al., 2007). The isoflavone 
glucosides are converted to isoflavone aglycones during soybean processing and 
upon the addition of β-glucosidase (Toda et al., 2001). It has been reported that lactic 
acid bacteria such as lactobacilli posses β-glucosidase and thus able to biotransform 
isoflavone glucosides to aglycones during fermentation of soymilk (Chien et al., 
2006; Otieno & Shah, 2007; Raimondi et al., 2009). Izumi et al. (2000) stated that 
soy isoflavone aglycones were absorbed faster and in higher amounts than their 
glucosides in human. Furthermore, Setchell et al. (2002) also reported that isoflavone 
glucosides were hardly absorbed intact across the intestinal epithelium, and intestinal 
β-glucosidases are needed for hydrolysis in order to improve the bioavailability of 
these glucosides. Therefore, the incorporation of β-glucosidase possessing 
lactobacilli could enhance the bioconversion of isoflavone glucosides to aglycones in 
soymilk and hence exert health benefits to human upon consumption. 
Taking into consideration the health beneficial effects of biologically active 
isoflavone aglycones, enhanced accumulation of aglycones in fermented soymilk is 
desirable. However, diffusion of isoflavone glucosides/ enzyme β-glucosidase across 
the cellular membrane has become the rate-limiting step to achieve effective 
transformation of isoflavone glucosides to aglycones. The cellular membrane played 
an important role in controlling the movement of substances in and out of a cell in 
order to maintain viability and metabolic functions of cells (Chen, 2007). Thus, 
enhanced membrane permeability is essential to ease the movement of 
substrates/enzymes across the cytoplasmic membrane to attain increased 
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bioconversion of isoflavones. Physical treatments such as ultrasonication, 
electroporation and UV radiation have been shown to enhance membrane 
permeabilization. Each physical treatment has its own characteristic with respect to 
cell viability, transfer efficiency, general applicability and technical requirements 
(Stephens & Peppercock, 2001). Exposure of cellular membrane to physical 
treatment with appropriate intensity could exert permeabilization that is reversible 
(Kotnik & Miklavčič, 2006). The permeabilization of cell membrane has been shown 
to induce the release of intracellular metabolites which in turn contributed to higher 
productivities especially during whole-cell bioprocesses (Nguyen et al., 2009; 
Tryfona & Bustard, 2008; Hung & Liao, 1996). To our knowledge, the cell 
permeability issues have been demonstrated well in molecular engineering as well as 
recombinant DNA technology (Chen, 2007). However, no effort has been made on 
the cellular membrane of lactobacilli to investigate their isoflavone bioconversion 
properties by using physical treatments. Furthermore, the prolonged effect of such 
treatments on subsequent few subcultures of treated cells and their isoflavones 
bioconversion ability in soymilk remains unknown. 
 The exposure of cells to physical treatments could alter the surface 
constituents such as proteins and lipids and the organizations of these constituents 
within the cell wall and cellular membrane. This has led to alteration in membrane 
surface following changes in physico-chemical properties of bacteria cells (Schär-
Zammaretti & Ubbink, 2003). As a consequence of such modification, the probiotic 
properties of lactobacilli that are closely related to the structure of the bacterial 
surface may have been affected, despite it being a promising member of probiotics. 
To date, no study has been done on the evaluation of probiotic properties on 
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physically treated lactobacilli and the sustainability of the treatment in affecting the 
probiotic properties for subsequent few subcultures.   
 1.2 Aims and Objectives of Research 
 The aim of this study was to evaluate the effects of B-vitamins on the 
viability, growth characteristics and bioconversion of isoflavones by lactobacilli in 
soymilk, and the effects of physical treatments on bioconversion of isoflavones in the 
B-vitamin-supplemented lactobacilli-fermented soymilk. The sustainability of the 
treatments on the treated cells in affecting the growth and bioconversion of 
isoflavones for few subcultures were also examined. Thus, the specific objectives 
were: 
1. To examine the effects of B-vitamins on bioactive potentials of lactobacilli-
fermented soymilk. 
2. To evaluate the effects of physical treatments (ultrasonication, electroporation 
and UV radiation) on membrane properties, growth and isoflavones 
bioconversion abilities of lactobacilli in B-vitamin-supplemented soymilk.  
3. To investigate the potential inheritance of the effects of physical treatments 
on lactobacilli based on their growth and bioconversion of isoflavones for the 
subsequent three subcultures.  
4. To examine the effects of physical treatment on probiotic properties of 
lactobacilli and sustainability of the treatments for the subsequent three 
subcultures.   
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CHAPTER 2  
LITERATURE REVIEW 
 
2.1 Probiotics 
With the increasing accumulation of scientific evidence on the properties, 
functionality and benefits of probiotics for the enhancement of human health, 
probiotic bacteria has gained an important role in the context of human nutrition. 
Probiotics are viable microorganisms that confer health benefits to the host once 
consumed in adequate amounts, primarily to promote the proliferation of beneficial 
gastrointestinal indigenous microflora. The important factors that must be possessed 
by probiotics when being used in food are the capability to survive passage through 
the digestive tract, acid and bile tolerance and the ability to proliferate in the gut 
(Stanton et al., 2001). Therefore, probiotics that are predominantly selected for use in 
the commercial food industries are bacteria that inhabit the human intestinal tract 
(Crittenden et al., 2005). Strains of lactobacilli such as Lactobacillus acidophilus, L. 
casei and L. gasseri are the intestinal microflora that commonly associated with 
probiotic properties. 
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2.1.1  Lactobacillus 
Lactobacillus is a gram-positive, non-spore-forming and non-flagellated rod-
shaped bacterium, varying from long and slender to short coccobacilli, occasionally 
forming short chains. The optimum growth temperatures of lactobacilli occur within 
35−40 ºC. Of all the species of lactobacilli that have been recognized, the most 
commonly suggested strains for dietary use are Lactobacillus acidophilus. Other 
representative species of Lactobacillus are L. johnsonii, L. bulgaricus, L. gasseri, L. 
casei, L. rhamnosus and L. plantarum (Ishibashi & Yamazaki, 2001). Lactobacillus 
is either aerotolerant or anaerobic, strictly fermentative and have complex growth 
requirements. They require carbohydrates, amino acids, peptides, fatty acid esters, 
salts, nucleic acid derivatives, minerals and B-vitamin complex (Gomes & Malcata, 
1999). Lactobacilli can metabolize glucose moiety chiefly to lactic acid via the 
homofermentative pathway or to equimolar amounts of lactic acid, CO2, ethanol, 
acetate, formate or succinate via the heterofermentative pathway. 
2.1.2 General Health Benefits of Probiotics
 
Lactobacilli are among the predominant members of the intestinal beneficial 
microbiota which are commonly associated with probiotics. Probiotics such as 
lactobacilli and bifidobacteria constitute approximately one-third of the bacterial 
population in the intestinal tract at their optimum level. Therefore, probiotic 
microorganisms have been regarded as a marker of the stability of the human 
intestinal microflora, for prevention of many diseases and for maintaining good 
health (Reyed, 2007). 
In general, several mechanisms have been suggested by which probiotics 
protect the host against intestinal infections. One of the proposed mechanisms is 
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competitive colonization. In order for antibiotic-resistant bacteria to cause infection, 
these bacteria must colonize the site of the infection. Colonization subsequently 
progresses to infection when there is a break in the skin or mucous membrane which 
enables the opportunistic pathogen to evade the host defense. Therefore, the ideal 
approach to treat antibiotic-resistant infections is by competitive colonization of the 
infected site with susceptible strains. Probiotics provide a new line of potential 
therapy because they could effectively decolonize the antibiotic-resistant strains 
without increasing the risk of future resistance. By encouraging the re-growth and 
repopulation of probiotic strains, the resistance level could be controlled by out-
competing the potentially pathogenic antibiotic-resistant strains. 
Colonization with probiotics could possibly counteract the colonization of 
antibiotic-resistant strains, given the ability of probiotics to bind to the enteric 
epithelium and inhibit the adhesion of pathogenic strains. Competitive colonization is 
possible due to the relatively higher adhesion ability of probiotics compared to the 
antibiotic-resistant strains at the target site. Vesterlund et al. (2006) demonstrated 
that L. rhamnosus GG and Lactococcus lactis subsp. lactis were able to reduce the 
binding of Staphylococcus aureus to human
 
colonic mucosa by 39–44% due to their 
higher adhesion ability compared to the pathogenic strains. Therefore, probiotics are 
often chosen for their ability to adhere to epithelial cells. Adherent probiotics could 
reduce the viability of pathogenic bacteria. 
Manley et al. (2007) has proposed that competition for nutrients by probiotics 
could be a potential mechanism to clear intestinal infections. Under normal 
physiology, the gastrointestinal tract is such a rich source of nutrients that it may 
seem unfeasible that such mechanism could influence the composition of the gut 
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microflora. Nevertheless, it only requires the absence of one limiting essential 
nutrient to trigger this mechanism. Under limited nutrient conditions, probiotics 
could compete more efficiently for the essential nutrient than the antibiotic-resistant 
strains. This mechanism could have been partly responsible for the effectiveness of 
probiotics to eliminate or reduce antibiotic-resistant strains in the gut. L. rhamnosus 
GG has been suggested to compete with vancomycin-resistant Enterococcus faecalis 
(VRE) for consumption of essential nutrients (e.g., monosaccharide), leading to 
slower VRE growth (Manley et al., 2007). 
In addition to competitive colonization, probiotics could exert antimicrobial 
activity against various antibiotic-resistant strains. This antagonistic action is due to 
the production of antimicrobial substances such as bacteriocin and hydrogen 
peroxide. The use of bacteriocins is often preferred against the administration of 
antibiotics, as they are perceived to be more natural due to their long history of safe 
use in foods. Lacticin, the two-peptide (LtnA1 and LtnA2) lantibiotic produced by 
Lactococcus lactis subsp. lactis was reported to act against various Gram-positive 
pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), 
vancomycin-resistant Enterococcus faecalis (VRE) and penicillin-resistant 
Pneumococcus (PRP) (Galvin et al., 1999). The possible mode of action for lacticin 
towards Gram-positive pathogens involves a lipid II binding step by the LtnA1 
peptide, followed by insertion of LtnA2 peptide into the membrane. This leads to the 
formation of pores and ultimately cell death (Morgan et al., 2005). Therefore, 
bacteriocin and other antimicrobial peptides produced by probiotics could be 
promising therapeutic agents to treat antibiotic-resistant infections. 
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In fact, bacteriocin-producing probiotics could also be used to prevent the 
growth of antibiotic-resistant strains. The production of these antimicrobial factors in 
the
 
gut would have an antagonistic effect on the resistant strains, which would
 
confer 
a competitive advantage to the bacteriocin-producing bacteria in the 
microenvironment. The competitive exclusion of other microorganisms
 
from this 
niche would affect the overall composition of
 
the microbiota (Millette et al., 2008). 
Therefore, it is expected that bacteriocin-producing probiotics could reduce the 
colonization by antibiotic-resistant strains. 
The consumption of probiotics is capable of stimulating the immune system 
due to the ability of probiotics to enhance both cytokine and secretory 
immunoglobulin A (sIgA) production. Cytokines play a significant role in 
stimulating the immune response to pathogens by activating immune cells once a 
pathogen is encountered. The
 
chief function of sIgA is the prevention of the binding 
of foreign bacteria to epithelial cells and the penetration
 
of harmful microorganisms 
(Erickson & Hubbard, 2000). Thus, probiotics could protect the gastrointestinal tract 
from the invasion of pathogens and opportunistic bacteria, refers to subsequently 
reducing the risk of infection. In such cases, the use of antibiotics to treat illnesses 
would be reduced thereby limiting the development of antibiotic resistance. Gorbach 
(1996) demonstrated that Lactobacillus GG fed to adults was effective in treating 
gastrointestinal
 
illnesses without the need for antibiotics. The preventative potential 
of probiotics in patients suffering from infectious diarrhea and upper respiratory tract 
infections has led to the suggestion that they could be used as an alternative to 
antibiotic treatment, thus lowering the occurrence of antibiotic resistance. 
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Additionally, probiotics has also been associated with the treatment and 
prevention of antibiotic-associated diarrhea. The administration of exogenous 
probiotics has been found to regulate intestinal micobiota and stabilize antibiotic-
induced dysbiosis caused by antimicrobial action of antibiotics. Inflammatory bowel 
diseases (IBD) such as ulcerative colitis and Crohn‘s disease are associated with 
infections and alterations of the intestinal biota. Probiotics have been proven to be 
effective in various clinical trials to treat IBD and strains such as L. rhamnosus GG 
has been used (Zhang et al., 2005).    
Several in-vivo evidences have indicated that probiotics have been associated 
with the lowering of serum cholesterol. The administration of probiotic fermented 
milk (10
9 
bacteria per ml) to hypercholesterolemic human subjects has shown a 
decrease of 50% in serum cholesterol level (Shah, 2007). It has been suggested that 
probiotics could exert hypocholesterolemic effect via several possible mechanisms 
such as assimilation by growing cells or binding to the cell surface or incorporation 
into the cellular membrane (Liong & Shah, 2005a, 2005b). Apart from this, 
probiotics could deconjugate bile salt by bile salt hydrolase (BSH). The resulting free 
bile salts have limited re-absorption in the gut due to poor solubilisation and thus are 
more prone to be excreted in the faeces. This increases the demand for synthesizing 
new bile salts to replace those lost in faeces (cholesterol is the precursor to bile 
acids), resulting in a reduction of serum cholesterol.  
The ability of probiotics to reduce blood pressure has been elucidated through 
fermentation of food products in order to release bioactive peptides, such as the 
angiotensin-I converting enzyme (ACE) inhibitory peptides that play a crucial role in 
rennin-angiotensin system (RAS). Several evidences from in vitro and in vivo studies 
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have demonstrated the effects of probiotics on hypertension. A study was performed 
by Donkor et al. (2007) on the proteolytic activity of several dairy lactic acid bacteria 
cultures and probiotics as determinants of growth and in vitro ACE inhibitory 
activity in milk fermented with these single cultures. The authors reported that both 
Bifidobacterium longum and Lactobacillus acidophilus strains showed ACE 
inhibitory activity during growth. This was also supported by Ong & Shah (2008) 
who examined the release of ACE inhibitory peptides in Cheddar cheeses made with 
starter lactococci and probiotics. The authors observed that cheeses made with the 
addition of L. casei and L. acidophilus had higher ACE inhibitory activity after 24 
weeks at 4 ºC and 8 ºC than those without any probiotic adjunct, probably due to 
increased proteolysis. Moreover, ACE-inhibitory peptides have also been found in 
yogurt, cheese and milk fermented with L. casei sp. rhamnosus, L. acidophilus and 
bifidobacteria strains (Rhyänen et al., 2001). In one of the largest studies involving 
94 hypertensive subjects in a double-blind, placebo-controlled, randomized trial, 
Jauhiainen et al. (1996) found that the consumption of 150 mL milk fermented by L. 
helveticus twice a day for 10 weeks could decrease systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) by 4.1 mm Hg and 1.8 mm Hg, respectively. 
Probiotics are postulated to exert anti-carcinogenic effects as well, mainly via 
the reduction of pro-carcinogenic bacterial enzymes such as β-glucuronidase, 
nitroreductase and urease, and consequently decrease the risk of tumor development 
(Gomes & Malcata, 1999). It has been suggested that probiotics could suppress the 
growth of pathogenic microorganisms which are involved in the production of tumor 
promoters and pro-carcinogens via lowering pH in the colon (Liong, 2008). 
Additionally, studies also suggested that tumor suppressing ability of probiotics is 
attributed to binding properties by fractions of the cell wall skeleton of probiotics on 
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mutagens and the binding of heterocyclic amines by intestinal probiotics (Zhang & 
Ohta, 1991; Orrhage et al., 1994). Probiotics‘ anticarcinogenic effect has also been 
reportedly accredited to their ability to affect intestinal detoxification, transit and 
immune status (Cabana et al., 2007). In addition, Singh et al. (1997) found that the 
antitumor activities in colon and the reduction in the volume of tumor were attributed 
to a reduced expression of ras-p21 oncoprotein upon consumption of B. longum. 
Probiotics have also been advocated for the prevention and treatment of a diverse 
range of disorders, from acute gastroenteritis to intestinal neoplasia (Boyle et al. 
2006). By possessing systemic anti-neoplastic activity, probiotics play a crucial role 
in the prevention of colorectal cancer (Figure 2.1). Probiotics such as Lactobacillus, 
Streptococcus, and Lactococcus and in fermented milk products containing 
Bifidobacterium have shown various degrees of anti-mutagenic activities in the 
Salmonella typhimurium mutagenic assay (Renner and Münzner 1991; Hosoda et al. 
1992; Abdelali et al. 1995).  
2.1.3 Production of Vitamins 
Probiotics such as Lactobacillus sp. are microorganism that colonize the 
human gastrointestinal tract and are responsible in producing vitamins, short-chain 
fatty acids and other nutrients for their hosts (Hooper et al., 2002). Vitamins are a 
group of trace organic substances, which are essential for microorganisms growth 
and metabolism. The B-vitamins are water-soluble vitamins, comprising of thiamine, 
riboflavin, niacin, pyridoxine, pantothenate, biotin, folic acid and vitamin B12 
(cyanocobalamin). They have been reported to synthesize folic acid, niacin, thiamine, 
riboflavin, pyridoxine, cyanocobalamin and vitamin K, which are slowly absorbed by 
the body (Gomes & Malcata, 1999). However, the synthesizing ability and the 
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concentrations of the vitamins accumulated are strain dependent. Certain strains of 
bifidobacteria have shown the ability to synthesize biotin (Noda et al., 1994) but not 
riboflavin (Biavati & Mattarelli, 2006). B-vitamins could be synthesized in situ via 
fermentation using lactic acid bacteria such as L. lactis and L. bulgaricus 
(Hugenholtz & Kleerebezem, 1999; Kleerebezem & Hugenholtz, 2003). Tamine et 
al. (1995) had demonstrated that cultured dairy products contained higher contents of 
folic acid, niacin, biotin, pantothenic acid, vitamin B6 and vitamin B12 compared to 
unfermented counterparts.    
 
Figure 2.1: The anti-neoplastic activities of probiotics in inhibiting the occurrence of 
colon carcinogenesis. 
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B-vitamins have been illustrated to play a crucial role in supporting the 
growth and metabolism of the probiotics by involving in various cellular functions. 
Thiamine is essential in the metabolism of carbohydrate. Intracellular thiamine is 
phosphorylated to form thiamine pyrophosphate that plays a role as a carrier of 
activated aldehyde groups in decarboxylation and transketolation reactions involved 
in acetyl-CoA formation, the citric acid cycle, and the branched chain amino acid 
biosynthesis (Schellenberger, 1998). Riboflavin has been found to be the direct 
precursor of cofactors for the formation of flavin mononucleotide (FMN) and flavin 
adenine dinucleotide (FAD). Both FMN and FAD are the essential components of 
redox cofactors of a number of dehydrogenases and oxidases in cellular metabolism 
of bacteria. 
Niacinamide in the form of nicotinamide adenine dinucleotides or its 
phosphorylated form (NAD, NADH, NADP and NADPH) functions as a cofactor of 
numerous redox reactions in cellular metabolism in bacteria. They are involved in 
several classes of NAD-dependent enzymes such as DNA ligase, protein deacetylase 
and a variety of ADP-ribosyltransferases (Ziegler, 2000). NAD has been reported to 
be synthesized de vono from aspartic acid in bacteria cell (Rodionov et al., 2008). 
Calcium pantothenate acts as a component of coenzyme A (CoA) in biochemical 
reactions in which acyl groups are transferred or metabolized. The acyl carrier 
protein is also a pantothenate-containing cofactor which serves as a specific and 
soluble cofactor for fatty acid biosynthesis. The enzymes that mediate the synthesis 
of pantothenate are universal in pantothenate-synthesizing organisms (White, 2003).  
Biotin is an essential cofactor in carboxylation, decarboxylation and 
transcarboxylation reactions in prokaryotes (Hebbeln et al., 2007). During the 
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biosynthesis of fatty acids, biotin serves as a prosthetic group in acetyl CoA 
carboxylase in catalyzing the synthesis of malonyl coenzyme A (Mandelstam & 
Mcquillen, 1976). In addition, it also acts as a coenzyme of pyruvate carboxylase that 
could promote glucose metabolism (Xu et al., 2008). Folate is a vitamin that serves 
as a cofactor in 1-carbon transfer for DNA synthesis, pantothenate, glycine, serine 
and methionine (Lin & Young, 2000).  It is required in metabolic pathways such as 
methyl group biogenesis and synthesis of nucleotide, vitamins, and some amino 
acids. Most bacteria have been reported to synthesis folate de novo, which involves a 
multi-enzyme pathway made up of GTP, para-aminobenzoic acid (pABA) and L-
glutamate moieties (Crécy-Lagard et al., 2007).  
2.2  Soy 
 Soy (Glycine max) is a legume indigenous to East Asia, though the main 
cultivation areas are now North America (FAO, 2007). Soybean is high in protein 
and oligosaccharides such as raffinose and stachyose, which is known to promote 
indigenous microorganisms in the intestinal tract, though they may also cause 
unpleasant flatulence (Wang et al., 2003). However, the virtues of soybean have 
been declared; evidenced by the long history of consumption of more than 1000 
years. The relatively low cost of soybean protein compared with animal proteins and 
the simple way it can be fashioned into palatable high protein food such as tofu and 
soymilk contributes to its role as a an alternative protein source (Ang et al., 1985). It 
is also low in fat and is an excellent dietary fiber and a variety of micronutrients and 
phytochemicals (Messina, 1999a).  
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2.2.1 Soy Foods as Carriers for Probiotics  
Soy products have been used to emulate the ―probiotic delivery vehicle‖ role 
of dairy products. This feature is attributable to the high content of indigestible 
oligosaccharides present naturally in soy to serve as carbon source for the 
fermentation of probiotics. After fermentation, the flatulence causing 
oligosaccharides can be reduced to minimum level upon ingestion. Apart from the 
high α-galactosyl glucosides, the variable amount of soy protein provides pool of 
peptides and amino acids essential for growth of probiotics (Shihata & Shah, 2000). 
Soymilk, the aqueous extract of whole soybean, is one of the probiotic 
carriers that have grabbed attention for intensities investigation. Several studies have 
been performed using soymilk to grow promising probiotics such as Lactobacillus 
and Bifidobacterium (Chien et al., 2006; Wei et al., 2007; Otieno & Shah, 2007). 
These probiotics were able to achieve the cell counts to the suggested level of 10
7
 
CFU/mL upon fermentation in order to qualify as a probiotic food for humans 
(Ishibashi & Shimamura, 1993). During the growth of probiotics, the ability of the 
organisms to utilize the nutrients in the soymilk could lead to an increase in the 
concentrations of metabolites. Therefore, changes in the concentrations of crude 
protein, sugars, B-vitamins, organic acids in soymilk were detected (Hou et al., 
2000). Donkor et al. (2007) also reported that fermented soymilk could be converted 
into a rich functional product containing probiotics and bioactive compounds such as 
angiotensin-converting enzymes (ACE) inhibitors.  
Probiotics have also been shown to grow well in tofu-based medium as 
reported by Ng et al. (2008). Tofufa is a soft form of tofu that is made via 
coagulation of soymilk. It is also known as tofu-pudding and generally consumed as 
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an Asian dessert and served with sugar syrup. The growth of probiotics in tofufa has 
exceeded 10
6
 CFU/g and was maintained over storage of 9 days. The presence of 
probiotics in tofufa has contributed to an increased in the concentration of organic 
acids which exhibited a preservative effect. In addition, the probiotic strains studied 
also showed proteolytic activity leading to the production of bioactive peptides with 
ACE-inhibitory activity.  
Soy cream cheese has been developed lately and has been shown as a 
potential carrier for probiotic with potential antihypertensive property. Soy cream 
cheese was prepared from tofu and blended with various types of ingredients such as 
palm oil, carrageenan, pectin, maltodextrin and salt. It could sustain the viability of 
probiotic strain and was maintained beyond suggested therapeutic level of probiotics 
of 10
6
 CFU/g over storage for 20 days. Due to the metabolic activity of probiotics, 
the organic acids produced during growth decreased the pH of soy cream cheese 
which subsequently inhibited the growth of total aerobes and anaerobes (Liong et al., 
2009).      
Soy waste has been shown as a suitable growth medium base for L. 
acidophilus (Fung et al., 2008b). Soy whey and okara are soy wastes generated from 
the production of tofu and soy milk. The authors optimized the growth of a probiotic 
in soy whey medium supplemented with nitrogen sources using response surface 
methodology. Optimal growth of the probiotics in soy waste medium was found to 
be 6.15 (OD600) in the presence of nitrogen sources such as meat extract at 7.25 % 
(w/v), vegetable extract at 4.7 % (w/v) and peptone at 6.85 % (w/v).  Utilization of 
oligosaccharides and reducing sugars and accumulation of acids in the soy waste 
medium corresponded with the high growth response of probiotics.  
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Soy yogurt has also been shown to be a suitable medium for delivery of 
probiotics. Soy yogurt was prepared by addition of yogurt culture such as L. 
delbruekii spp. bulgaricus and Streptococcus thermophilus into soymilk followed by 
fermentation at 42 º C to suitable termination pH before being cooled to 4 º C. The 
selected probiotic cultures inoculated into soy yogurt showed applicable viability and 
their viability were maintained during prolonged storage. The use of yogurt culture in 
combination with probiotics has resulted in substantial proteolytic activity and 
subsequently higher concentration of released bioactive ACE inhibitors, which could 
confer health benefits to the host (Donkor et al., 2005).      
2.2.2 Health Benefits of Soy 
Soy rich diets have been associated with lower incidence of atherosclerosis, 
cancer, hypertension, and osteoporosis as well as the alleviation of menopausal 
symptoms (Peñalvo et al., 2004). Soy is also an excellent source of phytoestrogens, 
including the intensely researched isoflavones, daidzein and genistein (Gardner et al., 
2001). These isoflavones are involved in a variety of physiological modulation 
including regulation of cell growth, bone density and plasma lipids (Martin et al., 
2001). Additionally, work has also been carried out to further proven the beneficial 
effects to post-menopausal women, hypertensive, hypercholesterolemic, 
cardiovascular disease and cancer patients at preventive and curative stages (Xiao, 
2008).  
Apart from providing an alternative protein source, soy and soy products 
confer a wide range of other benefits. The hypocholesterolemic effect of soy has 
been achieved through the cholesterol-lowering properties of soy protein. This 
property is attributed to the amino acid composition of soy protein and some non-
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protein components, such as saponins, isoflavones, and phytic acid that may affect 
serum cholesterol (Dewell et al., 2006). It has been reported that increased 
consumption of soy protein has been associated with lower total
 
serum cholesterol, 
LDL cholesterol and triglyceride concentrations (Anderson et al., 1995). 
Furthermore, a recent study showed that consumption of soymilk diet resulted in a 
modest decrease in LDL-cholesterol concentrations and higher HDL-cholesterol 
(Matthan et al., 2007). Soy protein containing isoflavones has been shown to 
significantly
 
reduce serum total cholesterol, LDL cholesterol, and triacylglycerol
 
and 
significantly increase HDL cholesterol (Oboh, 2006; Zhan & Ho, 2005). In addition, 
soy protein containing enriched or depleted isoflavones has been shown to
 
significantly improve lipid profiles, while the reductions in LDL cholesterol were 
more significant in hypercholesterolemic than in normocholesterolemic
 
subjects 
(Taku et al., 2007). 
Soy foods have also been claimed to alleviate menopausal symptoms 
(Duncan et al., 1999). Intake of soy with isoflavones supplementation has been 
shown to alleviate menopausal symptom such as hot flashes (Han et al., 2002). In 
addition, soy isoflavones have also been hypothesized to exert estrogenic effects 
when in a low-estrogen environment, such as in postmenopausal women (Messina, 
1999b). The bioactive health beneficial compounds of isoflavones in soy merely 
credited to its aglycone forms. Several hormone-dependent disorders such as 
osteoporosis, cardiovascular disease and cancer could be prevented through the 
consumption of biologically active aglycone forms of isoflavones (Tsangalis et al., 
2005). Due to its unique pharmacological profile, soy could also act as a potent 
estrogen replacement therapy for postmenopausal women (Martin et al., 2001, Han 
et al., 2002).  
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Epidemiological studies showed that people with high soy isoflavonoids 
intake have lower rates of several types of cancers including breast, prostate and 
colon cancer (American Institute for Cancer Research, 2000). The high intake of 
isoflavone-rich soy by Asian population is hypothesized to contribute towards their 
relatively lower incidence of clinical cancers than the Western counterparts (Duncan 
et al., 1999). The protective effect of soy isoflavones on breast cancer development 
is suggested to be a hormonal effect involved in lowering circulating levels of 
unconjugated sex hormones. Isoflavones also could inhibit enzyme activity that 
would lead to the development of prostate cancer (Cornwell et al., 2004). Apart from 
soy isoflavones, soy protein isolate have been shown to suppress carcinogen 
activation contributing to reduce mammary and colon cancer incidences (Badger et 
al., 2005).   
The incidence and risk of osteoporosis is highly associated with 
postmenopausal women. Estrogen plays an important role in maintaining bone 
density by regulating the formation and reabsorption of calcium in bone (Nilsson & 
Gustafsson, 2002; Cornwell et al., 2004). Soy isoflavones have been suggested to be 
effective in maintaining bone mineral density in postmenopausal women (Morabito 
et al., 2002). Genistein was found to have modest bone-conserving properties when 
administered in low doses to ovariectomized, lactating rats (Anderson et al., 1995). 
A double blind, placebo controlled study of postmenopausal women showed 
significant increase in bone mineral density at the femoral neck after 12 months of 
daily administration of 54 mg genistein (Morabito et al., 2002).  
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2.3 Probiotics in Soymilk  
 Soymilk has been considered as a good medium for growing probiotics due to 
the presence of monosaccharide and oligosaccharides which are fermented by most 
of the probiotic strains. However, the unfavorable beany flavor, flatulence factors 
and the high contents of indigestible oligosaccharides limit the consumption of 
soybeans as raw food materials (Garro et al., 2004). Fermentation of soymilk with 
probiotics not only offers a means of preserving the soymilk but also confers health 
effects upon ingestion.    
2.3.1 Growth of Probiotics in Soymilk  
Dairy products have been used as the conventional carriers for probiotics 
before they are delivered to the human gastrointestinal tract (Klaenhammer et al., 
2007). In order to achieve desired therapeutic effects, the level of probiotic bacteria 
in the probiotic-fermented product must be available in sufficient numbers. As 
suggested by Schuler-Malyoth et al. (1968), at least 10
6 
CFU probiotic organisms per 
milliliter of cultured milk must be present when consumed. By having superior 
nutritional characteristic such as high quality protein, varying sources of 
carbohydrates and a small quantity of saturated fatty acids (Scalabrini et al., 1998), 
soymilk has the potential to support the growth and biochemical activities of various 
lactic acid bacteria (Garro et al., 1998) and bifidobacteria (Chou & Hou, 2000).  
Probiotics have been reported to produce various glycosyl enzymes 
simultaneously that enable the microorganisms to hydrolyze various glycosidic 
bonds (Amaretti et al., 2006). The suitability of soymilk as a probiotic carrier is 
attributed to the ability of probiotics possessing various glycosyl hydrolases which 
enable them to utilize glycosyl sugars such as raffinose and stachyose for growth. 
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Liong et al. (2009) reported that the ability of probiotics to proliferate in soy-based 
cream cheese was attributed to their α-galactosidase activity. 
Upon hydrolysis by probiotics, the oligosaccharides in soymilk are broken 
down into simple sugars. The glucose moiety could be metabolized via 
homofermentative or heterofermentative pathway by lactobacilli while bifidobacteria 
breakdown glucose via the fructose-6-phosphate shunt. In addition to glucose, 
lactobacilli and bifidobacteria are also capable of utilizing fructose as a carbon 
source (Gomes & Malcata, 1999). Caescu et al. (2004) demonstrated that 
intracellular fructose was metabolized via the fructose-6-phosphate phosphoketolase 
pathway.  
A series of metabolic activities occur during the fermentation of probiotics in 
the soymilk, such as the production of organic acids and a decline in pH. Being 
homofermentative, both L. acidophilus and L. gasseri ferment glucose predominantly 
to lactic acid via the Embden-Meyerhof-Parnas pathway, accompanied by the 
production of minor amounts of acetic acid while heterofermentative L. casei and L. 
fermentum metabolize glucose via pentose phosphate pathway to produce equimolar 
amount of lactic acid/ethanol and CO2 as the end-products. On the other hand, the 
metabolism of carbohydrates by Bifidobacterium strains follow the fructose-6-
phosphate shunt, yielding 2 moles of lactic acid and 3 moles of acetic acid per mole 
of glucose in pure glucose medium as carbon source.  
2.3.1(a) Improvement of Viability  
 In order to provide a more favorable growth condition for probiotics, several 
methods have been applied during the fermentation of soymilk. Owing to glucose 
being the main carbon source for the metabolism of probiotics, Chou & Hou (2000) 
